A Food and Drug Administration advisory committee is expected to vote Thursday on whether Philip Morris International Inc. has made a convincing case that it should be allowed to market its IQOS tobacco heating device in the U.S. as less harmful than cigarettes.

The findings, which are to be released at the end of a two-day meeting, could help chart a new course for tobacco regulation in the U.S. and have enormous implications for U.S. public health. The stakes are also high for the Marlboro maker, which has invested more...  